600535:SHA
Tasly Pharmaceutical Group Co Ltd
14,04 CN¥
arrow_downward
-0,35%(-0,050) 1D
16-окт., 15:00:00 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
14,18 CN¥
High
14,35 CN¥
Low
13,92 CN¥
Mkt. cap
20,87 млд
Avg. vol.
11,45 млн
Volume
15,72 млн
Dividend
2,42%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026-ж., 29-май
P/E ratio
17,15
52-wk high
16,24 CN¥
52-wk low
12,90 CN¥
EPS
0,82 CN¥
Shares outstanding
1,51 млд
No. of employees
11 миң
Open
14,18 CN¥
High
14,35 CN¥
Low
13,92 CN¥
Mkt. cap
20,87 млд
Avg. vol.
11,45 млн
Volume
15,72 млн
Dividend
2,42%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026-ж., 29-май
P/E ratio
17,15
52-wk high
16,24 CN¥
52-wk low
12,90 CN¥
EPS
0,82 CN¥
Shares outstanding
1,51 млд
No. of employees
11 миң
Related stocks
News stories
From web sources and news partners
Seeking Alpha
·
47 мүнөт мурун
Nasdaq plunges 2% and these 15 names have led the downward decline
The Motley Fool
·
1 саат мурун
The Stock Market Has Seen This Happen Only 2 Other Times in Over 150 Years, and History Has an Ominous Warning for Investors
Simply Wall Street
·
1 саат мурун
Walmart (WMT) Adds Premium Wellness Products To More Than 2,300 Stores
CNBC
·
2 саат мурун
Anything not tied to artificial intelligence took off this week
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd